Personalis, Inc.
NASDAQ:PSNLMedical - Diagnostics & Research
+$0.34 today
- Market cap
- $1.62B
- Beta
- 2.28
- P/E (TTM)
- -11.0
- EPS (TTM)
- -$0.92
Volume 1.47M
Average 2.31M
PSNL Account Payables
Amounts the company owes suppliers for goods and services received.
Personalis, Inc.NASDAQ: PSNL
Account Payables · Q1 FY2026 · quarter ended Mar 2026
Account payables rises 60.2% from a year ago
Account payables stood at $12.68M at the end of Q1 FY2026, up 60.2% from a year earlier and down 2.4% from the prior quarter. Over 3 fiscal years it compounded at +0.3% a year.
Context
- Account payables amounted to 3.9% of total assets at the end of Q1 FY2026, up 1.0 pp from a year earlier.
- Account payables increased in 2 of the last 3 fiscal years.
What to watch
Whether account payables keeps rising in the next quarterly balance sheet after a +60.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Account Payables history
USD · from the balance sheet
- Latest · FY2025
- 12.99M USD
- Year-over-year change
- +103.0%
- 4-year CAGR
- +8.9%
| Period | Period end | Account Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 12.99M | +103.0% |
| FY2024 | 2024-12-31 | 6.4M | -57.1% |
| FY2023 | 2023-12-31 | 14.92M | +16.1% |
| FY2022 | 2022-12-31 | 12.85M | +39.4% |
| FY2021 | 2021-12-31 | 9.22M | — |
Account Payables vs competitors
How PSNL compares with its peers on the latest reported figures
- PSNL's Mar 2026 account payables of $12.68M is the 6th highest of the 10 companies compared; the peer median is $21.13M.
- Its year-over-year change of +60.2% is the 4th highest of 10, against a peer median of +46.1%.
- Account payables amounts to 3.9% of total assets for PSNL, versus a peer median of 1.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $102.51M | +408.9% | -7.6% | 5.4% | |
| Jun 2026 | $100.46M | +265.4% | +4.0% | 7.4% | |
| Jun 2026 | $75.15M | +103.8% | +2.1% | 2.8% | |
| Mar 2026 | $32.6M | +16.0% | +1.4% | 4.8% | |
| Mar 2026 | $21.13M | +15.8% | -6.9% | 1.8% | |
| Mar 2026 | $12.68M | +60.2% | +0.3% | 3.9% | |
BLLNBillionToOne, Inc. | Jun 2026 | $12.21M | +53.6% | — | 1.7% |
| Jun 2026 | $8.02M | -29.9% | -27.2% | 0.5% | |
| Jun 2026 | $7.24M | +15.2% | -50.8% | 0.3% | |
WGSGeneDx Holdings Corp. | Jun 2026 | $5.15M | +46.1% | -62.3% | 1.1% |
| Peer median (excluding PSNL) | $21.13M | +46.1% | -7.2% | 1.8% | |
Competitors are the stored peer set for PSNL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 105.59M | 89.13M | 56.98M | 91.42M | 124.25M |
| Short-term Investments | 181.48M | 78.53M | 57.2M | 93.59M | 115.71M |
| Net Receivables | 18.47M | 16.64M | 17.73M | 8.14M | 16.2M |
| Inventory | 4.08M | 6.38M | 5.66M | 3.98M | 6.14M |
| Other Current Assets | 1.53M | 9.02M | 9.17M | 5.89M | 5.65M |
| Total Current Assets | 318.23M | 199.7M | 146.74M | 203.02M | 267.95M |
| Property, Plant & Equipment (Net) | 73.47M | 88.42M | 75.22M | 64.73M | 59.93M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 4.83M | 4.59M | 3.14M | 2.53M | 6.28M |
| Total Non-current Assets | 78.3M | 93M | 78.36M | 67.25M | 66.21M |
| Total Assets | 396.53M | 292.7M | 225.1M | 270.27M | 334.16M |
| Account Payables | 9.22M | 12.85M | 14.92M | 6.4M | 12.99M |
| Short-term Debt | 1.81M | 2.22M | 1.65M | 1.67M | 1.19M |
| Tax Payables | 121K | 123K | 37K | 0 | 0 |
| Deferred Revenue | 4.36M | 1.29M | 3.29M | 3.1M | 1.56M |
| Other Current Liabilities | 11.19M | 9.55M | 19.62M | 10.86M | 12.8M |
| Total Current Liabilities | 31.31M | 33.13M | 47.23M | 31.13M | 39.63M |
| Long-term Debt | 0 | 0 | 0 | 0 | 31.87M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 2.12M | 389K | 10.1M | 1.3M | 1.48M |
| Total Non-current Liabilities | 54.91M | 41.43M | 48.42M | 36.19M | 33.35M |
| Total Liabilities | 86.23M | 74.56M | 95.66M | 67.31M | 72.98M |
| Common Stock | 4K | 5K | 5K | 9K | 10K |
| Retained Earnings | (247.1M) | (360.41M) | (468.71M) | (549.99M) | (631.26M) |
| Accumulated OCI | (166K) | (912K) | (222K) | (23K) | 104K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 310.3M | 218.14M | 129.44M | 202.96M | 261.19M |
| Total Debt | 58.33M | 48.65M | 47.73M | 44.25M | 39.95M |
| Net Debt | (47.25M) | (40.48M) | (9.26M) | (47.17M) | (84.3M) |
Personalis, Inc.
NASDAQ:PSNL
Intrinsic Alpha fair value
Locked
Current Price
$14.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.